Skip to main content

Donanemab Dosage

Medically reviewed by Drugs.com. Last updated on Apr 1, 2025.

Applies to the following strengths: azbt 17.5 mg/mL

Usual Adult Dose for Alzheimer's Disease

Initial dose: 700 mg IV every 4 weeks for 3 doses
Maintenance dose: 1400 mg IV every 4 weeks

Comments:


Use: For the treatment of Alzheimer's disease in patients with mild cognitive impairment or mild dementia stage of disease

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

This drug can cause amyloid related imaging abnormalities (ARIA) with edema (ARIA-E) and ARIA with hemosiderin deposition (ARIA-H).

For Patients With ARIA-E:
Clinically asymptomatic and ARIA-E severity on MRI is:


Clinically mild symptoms and ARIA-E severity on MRI is:

Clinically moderate or severe symptoms and ARIA-E severity on MRI is:

For Patients With ARIA-H:
Clinically asymptomatic and ARIA-H severity on MRI is:

Clinically symptomatic and ARIA-H severity on MRI is:

Patients who develop intracerebral hemorrhage greater than 1 cm in diameter during therapy: Suspend dosing until MRI shows radiographic stabilization and symptoms, if present, resolve.

Precautions

US BOXED WARNING:


CONTRAINDICATIONS:

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

IV compatibility:

Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.